Communicating complex science in a way that the public can understand is crucial. A new study from the University of Adelaide reveals that in scientific societies, women are shouldering the bulk of this work 鈥 often voluntarily 鈥 due to societal expectations and a sense of duty.
Viruses known as 鈥渏umbo phage鈥 are a new hope against the rising antibacterial infection crisis. Researchers have discovered how jumbo phage are able to infect bacteria so efficiently. They found a compartment that protects and hides valuable DNA material from the bacteria鈥檚 immune defense system.
Iowa State researchers are building "digital twins" that are regularly updated with data from their physical twins. A national committee said digital twins have "immense promise in accelerating scientific discovery and revolutionizing industries."
Researchers at WashU Medicine found that a small population of immune cells in the mouse intestine prevents allergic responses to food, suggesting that targeting such cells therapeutically could potentially lead to a new treatment for allergies.
In a major leap forward for microelectromechanical systems (MEMS) technology, researchers have unveiled a novel miniaturized accelerometer that can boost sensitivity, reducing noise and bias instability while maintaining compact chip size. The innovation centers around a novel anti-spring mechanism featuring pre-shaped curved beams, which enables stiffness softening without requiring large bias forces or displacements.
All states should adopt updated screening protocols so more newborns with cystic fibrosis can be diagnosed in the first weeks of life, when interventions can have the greatest benefit, according to the Cystic Fibrosis Foundation guidelines published April 2 in the International Journal of Neonatal Screening.
Researchers at the Johns Hopkins Applied Physics Laboratory (APL) in Laurel, Maryland, are advancing robotic perception capabilities by using artificial intelligence (AI) to equip autonomous agents with the capacity to make sense of unstructured environments and make plans like humans.
A powerful new software platform called the Playbook Workflow Builder is set to transform biomedical research by allowing scientists to conduct complex and customized data analyses without advanced programming skills. An article that describes the new platform was published in the April 3 online issue of the journal PLOS Computational Biology. Developed by a multi-institutional team that was led by Icahn School of Medicine at Mount Sinai investigators as part of the National Institutes of Health Common Fund Data Ecosystem (CFDE) program, researchers from across the United States developed the web-based platform that enables scientists to analyze and visualize their own data independently through an intuitive, interactive interface.
Microbial organisms 鈥 particularly Bacteria 鈥 dominate life on Earth, yet tracing their early history and how they have developed over time has long eluded scientists because they rarely fossilize.
In 2022, the American Cancer Society (ACS) updated its nutrition and activity guidelines for cancer survivors, recommending they avoid obesity, stay physically active, eat a healthy diet, and limit alcohol intake. New research by ACS scientists shows a lifestyle aligned with these guidelines is associated with a lower mortality risk among non-smoking survivors of obesity-related cancers in the United States.
Nitrous oxide鈥攂etter known as "laughing gas"鈥攃an potentially transform treatment for tough-to-beat depression. This centuries-old anesthetic gas targeted specific brain cells in mice and quickly reduced symptoms, according to new research from the Perelman School of Medicine at the University of Pennsylvania, reported today in Nature Communications.
Chemists at the U.S. Department of Energy鈥檚 (DOE) Brookhaven National Laboratory and Idaho National Laboratory report that radiation-induced chemical reactions may help mitigate the corrosion of metals in a new type of nuclear reactor cooled by molten salts.
In a study co-led by the University of Maryland School of Medicine (UMSOM), researchers have identified a 鈥渕aster regulator鈥 gene, ZNFX1, that may act as a biomarker to help guide treatment in future clinical trials involving patients with therapy-resistant ovarian cancer, according to a study recently published in Cancer Research.
A new multi-center study co-led by scientists from UCLA Health has uncovered critical genetic insights into a group of rare disorders affecting intestinal epithelial cell function, paving the way for targeted therapies that could significantly improve patient outcomes.